Laboratory of Biomedical Science, The Feinstein Institute for Medical Research, Manhasset, NY, USA.
Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Mol Med. 2021 Jun 7;27(1):58. doi: 10.1186/s10020-021-00307-1.
High mobility group box 1 (HMGB1) is a nuclear protein with extracellular inflammatory cytokine activity. It is passively released during cell death and secreted by activated cells of many lineages. HMGB1 contains three conserved redox-sensitive cysteine residues: cysteines in position 23 and 45 (C23 and C45) can form an intramolecular disulfide bond, whereas C106 is unpaired and is essential for the interaction with Toll-Like Receptor (TLR) 4. However, a comprehensive characterization of the dynamic redox states of each cysteine residue and of their impacts on innate immune responses is lacking.
Primary human macrophages or murine macrophage-like RAW 264.7 cells were activated in cell cultures by redox-modified or point-mutated (C45A) recombinant HMGB1 preparations or by lipopolysaccharide (E. coli.0111: B4). Cellular phosphorylated NF-κB p65 subunit and subsequent TNF-α release were quantified by commercial enzyme-linked immunosorbent assays.
Cell cultures with primary human macrophages and RAW 264.7 cells demonstrated that fully reduced HMGB1 with all three cysteines expressing thiol side chains failed to generate phosphorylated NF-КB p65 subunit or TNF-α. Mild oxidation forming a C23-C45 disulfide bond, while leaving C106 with a thiol group, was required for HMGB1 to induce phosphorylated NF-КB p65 subunit and TNF-α production. The importance of a C23-C45 disulfide bond was confirmed by mutation of C45 to C45A HMGB1, which abolished the ability for cytokine induction. Further oxidation of the disulfide isoform also inactivated HMGB1.
These results reveal critical post-translational redox mechanisms that control the proinflammatory activity of HMGB1 and its inactivation during inflammation.
高迁移率族蛋白 B1(HMGB1)是一种具有细胞外炎症细胞因子活性的核蛋白。它在细胞死亡时被动释放,并由许多谱系的活化细胞分泌。HMGB1 包含三个保守的氧化还原敏感半胱氨酸残基:位置 23 和 45 的半胱氨酸(C23 和 C45)可以形成一个分子内二硫键,而 C106 未配对,对于与 Toll 样受体(TLR)4 的相互作用是必不可少的。然而,每个半胱氨酸残基的动态氧化还原状态及其对固有免疫反应的影响的全面表征尚缺乏。
在细胞培养中,通过氧化还原修饰或点突变(C45A)重组 HMGB1 制剂或脂多糖(E. coli.0111:B4)激活原代人巨噬细胞或鼠源巨噬细胞样 RAW 264.7 细胞。通过商业酶联免疫吸附试验定量测定细胞内磷酸化 NF-κB p65 亚基和随后的 TNF-α 释放。
用原代人巨噬细胞和 RAW 264.7 细胞进行的细胞培养表明,具有所有三个半胱氨酸表达巯基侧链的完全还原 HMGB1 未能产生磷酸化 NF-КB p65 亚基或 TNF-α。形成 C23-C45 二硫键,同时使 C106 保持巯基,对于 HMGB1 诱导磷酸化 NF-КB p65 亚基和 TNF-α 产生是必需的。C45 突变为 C45A HMGB1 证实了 C23-C45 二硫键的重要性,该突变消除了诱导细胞因子的能力。二硫键同工型的进一步氧化也使 HMGB1 失活。
这些结果揭示了控制 HMGB1 的促炎活性及其在炎症过程中失活的关键翻译后氧化还原机制。